Articles |
From the Departments of Pharmacology and Cell Biophysics (A.Y., M.W., S.Y., Y.M.) and Medicine (Pulmonary) (A.Y., S.G.), University of Cincinnati (Ohio) College of Medicine, and Tsukuba Research Laboratories (T.N., I.T., K.K.), Eisai Co Ltd, Ibaraki, Japan.
Correspondence to Dr A. Yatani, Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575.
| Abstract |
|---|
|
|
|---|
1 and skeletal ß and
2/
subunits were stably expressed in baby
hamster kidney cells. In this stable cell line, Ca2+
channels remained at high levels (>1000 fmol/mg protein, or 2700
channels per cell) over extended times. The expressed recombinant
Ca2+ channels displayed the voltage dependence of
activation and inactivation, unitary conductance, and pharmacology
characteristic of native cardiac L-type Ca2+
channels. Subsequent coexpression of the ß1-adrenoceptors
(150 to 300 fmol/mg protein) with the Ca2+ channels
resulted in cell responsiveness to the extracellular application of
isoproterenol. These results indicate that heterogeneous expression in
mammalian cells provides a useful system for studying both biophysical
analysis of Ca2+ channel properties and
receptor-coupled regulatory processes.
Key Words: Ca2+ channels ß1-adrenoceptors patch clamp baby hamster kidney cells
| Introduction |
|---|
|
|
|---|
Structurally, the L-type Ca2+ channel is a complex
of four proteins: the
1 subunit, which contains the
binding sites for Ca2+ channel blockers and forms
the ion-conducting pore; the
2/
subunit, a
disulfide-linked dimer; the intracellularly located ß subunit; and
the transmembrane
subunit.11 cDNAs for each of the
four subunits have been cloned from skeletal muscle. By use of these
cDNAs as probes, distinct gene products encoding analogous subunits
have been cloned from other tissues, including cardiac muscle. These
studies have revealed that the
subunit is expressed only in
skeletal muscle, whereas the
2/
subunit is
highly conserved in most tissues including heart. Expression studies in
several systems have also demonstrated that the
1
subunit is the functional component and determines the pore, gating,
and much of the pharmacology of the channel.12
The
1 and ß subunits of the purified skeletal muscle
Ca2+ channel are phosphorylated by cAMP-dependent
protein kinase (PKA), with the
1 subunit appearing to be
the primary substrate. In cardiac muscle, however, the target(s) for
phosphorylation by PKA is unclear.13 For example, in
Xenopus oocytes, cardiac Ca2+ channel
currents expressed by recombinant
1 subunits are not
increased by cAMP unless the ß subunit is coexpressed.14
In contrast, Ca2+ channel currents mediated by the
1 subunit expressed in Chinese hamster ovary (CHO) cells
are increased by cAMP-dependent phosphorylation.15 16
These differences may result from the lack of appropriate regulatory
components in oocytes. However, the oocyte membrane does contain
various amounts of a ß subunitresponsive endogenous
Ca2+ channel,17 18 and these are
modulated by phosphorylation.19 Such discrepancies have
served to render the oocyte expression system particularly problematic
for studies of Ca2+ channel regulation. In addition,
the presence of extensive infoldings of the oocyte membrane and highly
lipophilic compartments within the oocytes reduces effective exchange
with bulk solutions used in electrophysiological
measurements.20
To circumvent these complications, we stably coexpressed the cDNAs
encoding rabbit cardiac
1,21
skeletal ß,22 and skeletal
2/
21 subunits in baby hamster
kidney (BHK) cells23 and studied adrenergic regulation of
the resulting recombinant cardiac Ca2+ channel. BHK
cells were selected for study since these cells do not contain
detectable endogenous Ca2+ channels or
ß-adrenoceptors. In this stable cell line, designated BHKC112,
Ca2+ channels remain at high levels without
diminution over extended periods (>60 passages) and display gating,
conductance, and pharmacology of native L-type cardiac
Ca2+ channels. We further show that coexpression of
the ß1AR in BHKC112 cells results in Iso-dependent
modulation of the expressed Ca2+ currents.
| Materials and Methods |
|---|
|
|
|---|
1 subunit excised from the plasmid pCARD121
was ligated along with the dihydrofolate reductase selection gene
derived from pAdD26SV(A)24 into pKCR,25
yielding the plasmid pK4KC. cDNA encoding the rabbit skeletal muscle
2 subunit derived from pSPCA121 was ligated
into pKNH26 to form pCAA2, which includes a neomycin
resistance gene. cDNA encoding the rabbit skeletal muscle ß subunit
was reverse-transcribed from rabbit skeletal muscle total RNA and then
amplified by polymerase chain reaction (PCR) using primers
corresponding to nucleotides 80 to 102 (sense) and 1809 to 1835
(antisense) of the rabbit sequence.22 PCR was performed
for 35 cycles at 94°C for 1 minute, 68°C for 1 minute, and 72°C
for 3 minutes. The
1.8-kb PCR product obtained was subcloned into
M13mp18 and mp19 for confirmatory dideoxy sequencing before ligation
into pKCRH2,27 yielding the plasmid pCABE. Stable transfections were performed on BHK cells23 by modified calcium phosphate precipitation (CellPhect, Pharmacia) by using 5 µg each of pK4KC, pCAA2, and pCABE. BHKC112 cells were selected in DMEM containing 600 µg/mL G418 (a neomycin analogue) and 250 nmol/L methotrexate; cells were subsequently maintained in 5% fetal calf serum, 30 µg/mL streptomycin, 30 U/mL penicillin, 80 µg/mL G418, and 250 nmol/L methotrexate. Confirmation of expression of a DHP-sensitive Ca2+ channel was performed by Northern analysis, radioligand binding, and electrophysiological techniques as described below.
BHKC112 cells were transiently transfected with cDNA encoding the human ß1AR by calcium phosphate precipitation similar to that previously described.28 For these transfections, cells were maintained in DMEM supplemented with 10% fetal calf serum, 100 U/mL penicillin, and 100 µg/mL streptomycin. cDNA encoding the human ß1AR excised from the plasmid pBC12BI28 was ligated into the plasmid pcDNA-1/Neo (Invitrogen) under the control of the CMV early promoter, yielding the plasmid pcNeoß1. Plasmid DNA (20 to 40 µg) was used for each transfection. Cells were maintained in DMEM supplemented with 10% fetal calf serum and antibiotics and assayed when confluent (24 to 48 hours). Preliminary data indicated that BHKC112 cells transfected in this manner expressed detectable ß1AR for up to 5 days.
Northern Analysis
Total RNA was isolated from nontransfected BHK cells and from
BHKC112 cells by the single-step method of Chomczynski and
Sacchi.29 Total RNA (5 µg) was electrophoresed through
1% agarose/formaldehyde gels and transferred to nylon membranes by
standard techniques. Double-stranded cDNA probes for the
Ca2+ channel
1,
2, and ß subunits were prepared from the
following sources:
1, 2.1-kb
EcoRI/EcoRV fragment of pCARD321 ;
2, 2.4-kb HindIII fragment of
pSPCA121 ; and ß, 0.8-kb Pst I/Sca
I fragment of pCaB2.30 Each probe was then labeled by nick
translation. Hybridization was carried out at 42°C overnight,
membranes were washed, and autoradiographs were exposed for 72 hours at
-70°C.
Radioligand Binding
Ca2+ channel radioligand binding studies were
performed by methods similar to those previously
described.31 After the cells were washed with
Ca2+-free phosphate-buffered saline (PBS), confluent
BHKC112 cells in tissue culture dishes were used to prepare crude
membranes by mechanical disruption in 5 mmol/L Tris (pH 7.4) and 2
mmol/L EDTA buffer and centrifugation at 39 000g for 10
minutes at 4°C. Saturation binding studies were performed by
suspending membranes in assay buffer (50 mmol/L MOPS, pH 7.4) at
30
µg/mL and incubating for 2 hours at 22°C with 0 to 10 nmol/L
[3H]PN200-110 in a final volume of 500 µL. Nonspecific
binding was defined by 1 µmol/L nitrendipine. Reactions were stopped
by dilution and rapid filtration over glass fiber filters, which were
then counted in a scintillation counter.
For ßAR radioligand binding studies, membranes were prepared as
described above and suspended in 75 mmol/L Tris (pH 7.4), 12.5 mmol/L
MgCl2, and 2 mmol/L EDTA at a final concentration of
0.1 mg/mL before incubating with 400 pmol/L
[125I]cyanopindolol (ICYP) for 2 hours at 22°C.
Reactions were stopped by dilution and rapid filtration over glass
fiber filters. Nonspecific binding was defined by 1 µmol/L
propranolol. Competition assays were performed similarly, except that
incubations were performed in the presence of (final concentrations)
100 µmol/L GppNHp, 30 pmol/L ICYP, and varying amounts of competing
ligand as indicated. Both saturation and competition data were analyzed
by nonlinear techniques as described previously28 ; Hill
coefficients were typically close to 1.0. For all radioligand binding
assays, total counts bound were typically <10% of counts added.
Protein was measured by a copper bicinchoninic assay,32
with bovine serum albumin used as standard.
cAMP Determinations
Whole-cell cAMP determinations were assessed by radioimmunoassay
(RIA) similar to that previously described.33 BHKC112
cells were transfected with ß1AR cDNA as described above;
when confluent (24 hours), these were detached with 0.5% trypsin/EDTA
and seeded into 24-well culture dishes. Twenty-four to 48 hours later,
cells were washed three times with PBS and allowed to warm at 37°C
for 10 minutes in 450 µL PBS supplemented with 0.1 mmol/L ascorbic
acid. Iso was then added at varying concentrations into duplicate
wells, and reactions were terminated 10 minutes later by adding 50 µL
of 1N HCl. Aliquots of supernatant were acetylated, and cAMP content
was determined by RIA as previously described.33
Electrophysiology
For electrophysiological measurements, cells were seeded onto
glass coverslips and incubated in culture medium with fetal calf serum
for 1 to 3 days. Cells prepared in this manner were spherical and had
diameters of 10 to 20 µm when measured with an eyepiece micrometer at
x40 (x600 total magnification). The surface areas of cells were thus
between 314 and 1256 µm2, assuming that the cells
maintained a smooth spherical shape. Whole-cell and single-channel
currents were recorded by patch-clamp techniques as previously
described.34 Patch electrodes were coated with Sylgard and
had resistances of 2 to 5 M
. Whole-cell currents were
low-passfiltered (-3 dB) at 0.2 to 1 kHz and digitized at 0.5 to 5
kHz. Leak and capacitative currents were corrected by using a P/4
subtraction procedure unless noted otherwise. The external solution
contained (mmol/L) BaCl2 2, MgCl2 1,
tetraethylammonium chloride 135, 4-aminopyridine 5, glucose 10, and
HEPES 10 (pH 7.3 with Tris base). The pipette solution was (mmol/L)
cesium aspartate 110, CsCl 20, MgCl2 2, ATP 2, GTP 0.5,
EGTA 5, and HEPES 5 (pH 7.3 with Tris base). The membrane capacitance
of the cells was measured by using voltage ramps of 0.8 V/s from a
holding potential of -50 mV. The conductance-voltage relation
(G/Gmax) was determined by using an interactive
nonlinear regression fitting procedure to the Boltzmann equation:
G/Gmax=1/{1+exp[(V0.5-Vm)/k]},
where Vm is the membrane potential, V0.5 is the
midpoint potential, and k is the slope factor. Similarly,
voltage-dependent inactivation (I/Imax) was
determined by using the Boltzmann equation: I/Imax=
1/{1+exp[(Vm-V0.5)/k]}.
Single-channel currents were low-passfiltered at 1 to 2 kHz, digitized at 5 to 10 kHz, and analyzed as previously described.34 The patch electrodes contained (mmol/L) BaCl2 90, glucose 10, and HEPES 10 (pH 7.3 with Tris base). Cells were bathed in a high-KCl depolarizing solution containing (mmol/L) KCl 140, MgCl2 2, EGTA 5, and HEPES 5 (pH 7.3 with KOH). Curve fitting was performed by using a maximum likelihood estimator.
Solution changes were made by using a modification of Y-tube
techniques described by Nakagawa et al.35 A microcapillary
tube (0.1-mm diameter) was set
200 µm away from the cell being
recorded. Solutions were then delivered by a negative pressure of -40
cm Hg. After the pressure was released, external solution was emitted
from the outlet of the Y tube by gravity. Complete exchange
of the solution surrounding the recording cell can be achieved within
50 milliseconds. To avoid accumulation of test substances in the bulk
solution, the chamber was continuously perfused at 5 mL/min.
All experiments were performed at room temperature (20°C to 21°C). Mean±SEM values are given in the text. Comparisons between conditions were evaluated by using Student's t test, with significance imparted at the P<.05 level.
Materials
All radioligands were from New England Nuclear. BHK cells were
from American Type Culture Collection. DMEM and fetal calf serum were
from JRH Bioscience. G418 was from GIBCO BRL. pcDNA-1/Neo was from
Invitrogen. ICI 118551 and nitrendipine were from Research
Biochemicals, Inc. CGP20712 was a gift from CIBA-GEIGY. All other
reagents were from Sigma Chemical Co.
| Results |
|---|
|
|
|---|
1 and skeletal
2 and ß subunits
resulted in easily detectable mRNA expression for each subunit (Fig 1
|
|
Voltage-activated Ca2+ channel currents were
measured in the presence of 2 mmol/L Ba2+ (Fig 3
). Nontransfected BHK cells did not demonstrate
voltage-activated inward Ba2+ current
(IBa) (Fig 3A
), in agreement with radioligand binding data.
In contrast, BHKC112 cells expressed large inward
IBa, which inactivated slowly during 300-millisecond
depolarizing pulses (Fig 3B
). The size of peak inward IBa
was 861±117 pA (n=60; range, 110 to 3100 pA). The whole-cell current
properties were further analyzed by using cells expressing current
densities <1000 pA in order to avoid series resistance artifacts
associated with large current amplitude (Table
).
|
|
The voltage dependence of current activation was determined by
measuring the peak current elicited by depolarizing pulses to various
potentials. Typically, the inward current activated at a threshold
potential between -30 and -20 mV, peaked between -10 and 0 mV, and
reversed around +50 mV. Conductance was then calculated by dividing the
peak current by the driving force (Fig 3C
and Table
). It was difficult
to estimate the true reversal potential for the Ca2+
channels, because a small outward current in nontransfected cells
overlapped at positive potentials (Fig 3A
). Therefore, the apparent
reversal potential was obtained by extrapolating the peak
current-voltage (I-V) plot through the zero current axis. The
voltage-dependent channel inactivation was determined by applying
5-second depolarizing pulses to a series of different potentials (Fig 3D
). V0.5 and k values were determined from a Boltzmann
equation (Fig 3E
and Table
). These data demonstrate that the activation
and inactivation kinetics of expressed currents in BHKC112 cells are
comparable to the L-type Ca2+ channel seen in native
cardiac myocytes.4 36 As previously reported in various
cell types, we found that the Ca2+ channel currents
run down after the whole-cell recording configuration has been
established.3 In control experiments (n=10), we generally
observed that IBa initially increased in amplitude
immediately after puncturing the membrane and then exhibited rundown.
During rundown, peak inward current amplitude decreased by 50% at a
steady rate over 20 to 30 minutes.
The pharmacological properties of the channels expressed in BHKC112
cells are shown in Fig 4
. The DHP-agonist Bay K 8644
increased IBa in a concentration-dependent manner with an
average EC50 of 80 nmol/L (n=4, Fig 4A
). As in the case of
native cardiac cells, Bay K 8644 (1 µmol/L) shifted the I-V curve to
more negative potentials by 11.5±1.3 mV. The benzothiazepine
Ca2+ channel blocker diltiazem reversibly reduced
IBa with an average IC50 of 5 µmol/L (n=4,
Fig 4B
), without changing the I-V relations. Diltiazem at 5 µmol/L
shifted the voltage-dependent inactivation curves to more negative
potentials by 14.8±1.4 mV.
|
To examine the effects of cAMP-dependent phosphorylation on these
recombinant Ca2+ channel currents, a
membrane-permeable cAMP analogue, dibutyryl cAMP (dB-cAMP), was applied
to the cells. In the presence of dB-cAMP (50 µmol/L), the amplitude
of IBa gradually increased and reached a new steady state
level
3 minutes after application (Fig 5A
). Neither
the voltage-dependent activation nor inactivation was significantly
affected by dB-cAMP exposure (Fig 5B
). An average increase in
IBa of 22.9±5.6% was observed in seven cells of the 14
studied. The reasons for the failures of
50% of the experiments are
not known. As noted above, in most of the cells, IBa
declines gradually in control conditions. Thus, the varied effects
after dB-cAMP treatment are probably due to competition between the
slow increase in IBa due to dB-cAMP and the steady decrease
of control current. The membrane currents in nontransfected BHK cells
were not affected by the addition of dB-cAMP (n=10). Together, these
results indicate that increased levels of intracellular cAMP potentiate
Ca2+ channel currents expressed in BHKC112
cells.
|
Fig 6
shows single-channel recordings of BHKC112 cells
in the presence of 1 µmol/L Bay K 8644. Single-channel data obtained
from cell-attached patches also demonstrated the features of native
cardiac L-type Ca2+ channels. For example, the
open-state probability of the channel increased with depolarization
(Fig 6A
). From the I-V relations of unitary Ba2+
currents, a single-channel conductance of 24 pS was estimated (Fig 6B
).
This value correlates well with the value of 24 to 25 pS observed in
cardiac myocytes that was determined under identical
conditions.37 38 From whole-cell and single-channel
measurements (Figs 4A
and 6B
), we estimated the Ca2+
channel density in BHKC112 cells, assuming a probability of opening of
0.2 at 0 mV and a unitary current amplitude of 1.1 pA, to be
2700
channels per cell, or about three channels per square micrometer.
|
Functional Coupling of Ca2+ Channel Currents
With Coexpressed ß1ARs
We transiently transfected the ß1AR cDNA into
BHKC112 cells and determined receptor expression by radioligand
binding. Nontransfected BHKC112 cells expressing only the DHP-sensitive
Ca2+ channel demonstrated no detectable ICYP binding
(data not shown). In contrast, membranes from BHKC112 cells transfected
with pcNeoß1, as described in "Materials and
Methods," expressed
200 fmol ICYP binding sites per milligram
protein (range, 150 to 300 fmol/mg). It should be noted that because of
the transient nature of these transfections, only a portion of BHKC112
cells treated in this manner actually take up and express the
ß1AR; as a result, the receptor density obtained by
radioligand binding represents a mean value for all cells
treated, including those cells that failed to take up exogenous DNA.
Our previous experience with these assays has suggested that the actual
efficiency of transient expression (ie, the proportion of total cells
that express the recombinant protein of interest) is between 30% and
60% (S.A. Green and S.B. Liggett, unpublished data, 1994). As
described in detail below, we noted electrophysiological evidence of
ß1AR activity in 32 of 78 cells studied, a figure that is
consistent with this phenomenon.
The identity and functional nature of the expressed ßAR was confirmed
as the ß1AR subtype by competition binding and cAMP
determinations. As depicted in Fig 7A
, membranes
prepared from BHKC112 cells transfected with pcNeoß1
demonstrated rank-order antagonist profiles typical of
ß1AR receptors.28 In addition, transfection
of pcNeoß1 conferred Iso responsiveness for cAMP
accumulation in whole cells, which was not observed in nontransfected
BHKC112 cells (Fig 7B
). This response confirms the presence of
ß1AR functionally coupled to the
Gs/adenylyl cyclase pathway.
|
Potentiation of IBa in BHKC112 cells transfected with the
ß1AR was examined with various concentrations of Iso. An
increase in IBa was detectable with 10 nmol/L Iso and
reached a maximum at
10 µmol/L. As noted above, an effect of Iso
on IBa was observed in 32 of 78 cells transfected with the
pcNeoß1. An increase in the Ca2+
channel currents by Iso was not observed in BHKC112 cells not
transfected with the ß1AR (n=24), consistent with the
lack of ßAR measured by the radioligand binding.
During the steady state exposure to Iso at a concentration of 10
µmol/L, the mean relative increase of IBa by Iso (10
µmol/L) was 2.39±0.35-fold (n=12, Fig 8A
and 8B
).
Several studies have reported that the ß-adrenergic stimulation of
Ca2+ channel currents causes a shift in the I-V
curve to more negative potentials.39 40 Therefore, we
examined the effects of Iso on the I-V relation of IBa. The
peak I-V relations before and after Iso exposure are illustrated in Fig 8D
. Iso increased IBa at all potentials measured without
changing the peak I-V relation. In four experiments, the
conductance-voltage relation was analyzed in the same way as described
in Fig 3C
. In the absence of Iso, the mean values of V0.5
and k were -6.8±3.5 and 4.5±0.6 mV. With 10 µmol/L Iso, the values
were -8.5±3.9 and 4.4±0.7 mV for V0.5 and k,
respectively. These results indicate that ß1-adrenoceptor
stimulation did not affect the voltage-dependent activation kinetics.
In most experiments, such as that depicted in Fig 8C
, the current
waveform appeared to be scaled, suggesting that the time course of
IBa was not altered by Iso. Fig 8E
depicts the
dose-response relations for Iso on IBa. Analysis of data by
nonlinear techniques using a one-to-one drug-receptor relation revealed
a mean EC50 of 231 nmol/L (n=5). Iso-mediated increases in
IBa were completely inhibited by 50 µmol/L propranolol
(data not shown).
|
The degree of increase in IBa by Iso was dependent on the
presence of guanine nucleotides; without GTP in the pipette solution,
in the presence of 10 µmol/L Iso, the magnitude of enhancement was
greatly reduced to 106±3% of control values (n=5). To further test
the involvement of a G protein pathway in the potentiation of
Ca2+ channel currents, cells were loaded with the
nonhydrolyzable GDP analogue GDPßS instead of GTP in the patch
pipette and were then depolarized from a holding potential of -80 to 0
mV every 10 seconds for 5 minutes. The relative current amplitudes of
IBa during this time were reduced by
15% to 20% (n=4).
No increase in IBa was observed after application of 10
µmol/L Iso, and the time course of the current amplitude was
indistinguishable from that in the control experiments.
| Discussion |
|---|
|
|
|---|
-adrenergic, ß-adrenergic, and
muscarinic receptor subtypes.41 Because of the coexistent
expression of different receptor subtypes with overlapping affinities
for commonly used agonists and antagonists, separation of
subtype-specific effects on native L-type Ca2+
channels is frequently problematic. To examine the relative functional
coupling of a particular receptor subtype to Ca2+
channels, experiments should ideally be performed with tissue or cells
expressing pure populations of the receptor of interest. To address
this, we stably expressed cardiac L-type Ca2+
channels in a mammalian cell line and subsequently examined the effects
of transiently expressed ß1ARs on the
Ca2+ channel regulation.
Our results indicate that this mammalian cell recombinant system can
provide a useful tool that may be superior to the commonly used oocyte
system for studying the regulation of Ca2+ channels.
The expression of Ca2+ channel currents in this
clonal cell line has been stable over extended periods with
reproducible results. This may avoid some of the technical limitations
associated with the oocyte expression system, including seasonal
variability in oocyte quality and time constraints imposed by the
transient expression system. Compared with oocytes, BHK cells have a
smaller size and offer improved voltage-clamp quality for biophysical
analysis of the channel. In addition, Ca2+
channels expressed in mammalian cells may undergo posttranslational
modifications and regulation processes in a manner more akin to that
occurring in native cells. For example, each
1 subunit
has multiple consensus sites for phosphorylation by PKA. In mammalian
cells, phosphorylation of the cardiac Ca2+ channel
1 subunit by cAMP increases Ca2+
channel currents,15 16 but Ca2+ channel
currents expressed in oocytes are not modulated by
cAMP.14
Previous studies have shown that expression of cardiac or smooth
muscle Ca2+ channel
1 subunit alone
in CHO cells produces functional DHP-sensitive Ca2+
channel currents.15 42 43 The DHP sensitivity, high
voltagedependent activation, and single-channel conductance of these
channel subunits are similar to those observed in native cells.
However, whole-cell recordings revealed some differences in their
biophysical properties. For example, expressed channels displayed
slower rates of activation and inactivation than those observed in
native cells. Coexpression of the
1 subunit with
Ca2+ channel ß and
2/
subunits from skeletal muscle in CHO cells increased the current
density and DHP-binding sites mediated by the
1
subunit.43 In addition, the coexpression produced rapid
activation and inactivation rates and shifts in the steady state
activation and inactivation to more negative potentials.
Therefore, in the present study, we expressed the cardiac
Ca2+ channel
1 subunit in combination
with the skeletal ß and
2/
subunits to
produce high-level expression and native celllike channel kinetics.
BHK cells transfected with the cDNAs of the
1,
ß, and
2/
subunits demonstrated specific
high-affinity [3H]PN200-110 binding with a
Kd of 0.81 nmol/L, a Bmax of 1230
fmol/mg protein, and a current density measured in the presence of 2
mmol/L Ba2+ of 19.45 A/F. These values are
comparable to those obtained in CHO cells expressing
Ca2+ channel
1, ß, and
2 subunits.43 Furthermore, the
Ca2+ channels expressed in BHKC112 cells exhibit
pharmacology, channel kinetics, and single-channel conductances
characteristic of native cardiac L-type Ca2+
channels.
Native cardiac Ca2+ channels are
phosphorylated by PKA, although the primary target subunit(s) for
phosphorylation is unclear.13 It has been previously shown
that CHO cells expressing cardiac Ca2+ channel
1 subunits alone are phosphorylated by
membrane-permeable cAMP or intracellular PKA.15 16 We
found that dB-cAMP increases IBa to an extent similar to
that observed in CHO cells.15 Recently Perez-Reyes et
al44 have reported that IBa in human embryonic
kidney (HEK) cells expressing cardiac L-type Ca2+
channel
1 and ß subunits did not increase by
phosphorylation unless endogenous kinases were previously inhibited.
Our observation that phosphorylation of Ca2+
channels expressed in BHKC112 cells leads to stimulation of
IBa comparable to the phosphorylation of CHO cells
indicates that the basal phosphorylation of BHKC112 cells is rather low
compared with HEK cells. Although this observation does not definitely
establish the
1 subunit as the sole target protein for
phosphorylation under our experimental conditions, the presence of a
cAMP-regulated component in the complete channels expressed in BHKC112
cells supports the use of this system for studying regulatory
mechanisms controlling Ca2+ channel activity.
As noted in the present study, Ca2+ channel currents in BHKC112 cells not transfected with the human ß1AR are not responsive to the external application of Iso. In agreement with these results, radioligand binding studies did not reveal measurable ßARs. Coexpression with ß1AR rendered the cell responsive to Iso. The ß1AR modulation of the recombinant cardiac Ca2+ channels by Iso is remarkably similar to that observed in native cardiac myocytes.1 3 4 The external application of Iso produced a concentration-dependent enhancement of Ca2+ channel current amplitudes. In contrast to the results of previous studies,1 3 4 several recent reports indicate that the Iso stimulation of Ca2+ channel currents causes changes in the voltage-dependent Ca2+ channel gating.39 40 In our experiments, potentiation of the current amplitude by Iso occurred at all membrane potentials, and the current waveform during depolarization was not affected by Iso, suggesting that the voltage-dependent parameters were not affected. The reasons for these differences are not clear. One possible explanation, however, is the contribution of other ßAR subtypes that may be present in native cells. For example, Xiao and Lakatta9 have noted that there are differences between ß1AR and ß2AR stimulation in their effects on Ca2+ channel currents; ß2AR but not ß1AR stimulation markedly prolonged the Ca2+ channel current inactivation time.
The maximum increase in the current amplitude by Iso in BHKC112 cells
was close to that observed in mammalian cardiac
myocytes.1 3 4 40 The maximum increase was a factor of 3
to 4; however, the EC50 value (
200 nmol/L) in BHKC112
cells was higher than that seen in native cells (
38 nmol/L). The
reason for this discrepancy is not clear. It is possible that an
additional cofactor involved in
ß1AR/Ca2+ channel coupling is not
present in BHK cells. However, other cellular components necessary
for the signal transduction, such as G proteins and adenylyl cyclase,
are clearly present, as indicated by our studies of cAMP
accumulation. The differences may therefore reflect coupling
characteristics specific to ß1ARs. Recent pharmacological
studies using mammalian cell lines that express ß1AR or
ß2AR exclusively indicate that these subtypes mediate
quantitatively different effects on Gsadenylyl cyclase
coupling.28 45 For example, Green et al28
found that although both receptors mediated equivalent maximal
increases in Iso-stimulated adenylyl cyclase activities, the
EC50 for the ß2AR was significantly lower
than that for the ß1AR. Therefore, it is possible that
the lower EC50 observed for Iso increases in
IBa in endogenous myocytes may in fact reflect a
contribution from the ß2AR that is not seen in our
recombinant system. Further study will be necessary to clarify this
relation.
In summary, our results show that heterologous expression in mammalian cells provides a useful system for studying functional properties of a Ca2+ channel protein. It is hoped that this system will facilitate the study of the receptor-mediated regulation of Ca2+ channel activities.
| Acknowledgments |
|---|
Received May 31, 1994; accepted November 9, 1994.
| References |
|---|
|
|
|---|
2.
Imoto Y, Yatani A, Reeves JP, Codina J, Birnbaumer L, Brown
AM. The
-subunit of Gs directly activates cardiac
calcium channels in lipid bilayers. Am J Physiol. 1988;255:H722-H728.
3. Yatani A, Brown AM. Rapid ß-adrenergic modulation of cardiac calcium currents by a fast G protein pathway. Science. 1989;245: 71-74.
4. Hartzell HC. Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems. Prog Biophys Mol Biol. 1988;52:165-247. [Medline] [Order article via Infotrieve]
5.
Pelzer S, Shuba YM, Asai T, Codina J, Birnbaumer L, McDonald
TF, Pelzer D. Membrane-delimited stimulation of heart cell calcium
current by ß-adrenergic signal-transducing Gs protein.
Am J Physiol. 1990;259:H264-H267.
6. Hartzell HC, Fischmeister R. Direct regulation of cardiac Ca2+ channels by G proteins: neither proven nor necessary? Trends Pharmacol Sci. 1992;13:380-385. [Medline] [Order article via Infotrieve]
7. Motomura S, Zerkowski H-R, Daul A, Brodde O-E. On the physiologic role of beta-2 adrenoceptors in human heart: in vitro and in vivo studies. Am Heart J. 1990;119:609-619.
8.
Dukes ID, Vaughan Williams EM. Effects of selective
1-,
2-, ß1- and
ß2-adrenoceptor stimulation on potentials and
contractions in the rabbit heart. J Physiol (Lond). 1984;355:523-546.
9.
Xiao R-P, Lakatta EG. ß1-Adrenoceptor
stimulation and ß2-adrenoceptor stimulation differ in
their effects on contraction, cytosolic Ca2+,
and Ca2+ current in single rat ventricular cells.
Circ Res. 1993;73:286-300.
10. O'Donnel SR, Wanstall JC. Responses to the ß2-selective agonist procaterol of vascular and atrial preparations with different functional ß-adrenoceptor populations. Br J Pharmacol. 1985;84: 227-235.
11. Hullin R, Biel M, Flockerzi V, Hofmann F. Tissue-specific expression of calcium channels. Trends Cardiovasc Med. 1993;3:48-53.
12. Catterall WA, Striessnig J. Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci. 1992;13:256-262. [Medline] [Order article via Infotrieve]
13. Haase H, Karczenski P, Beckert R, Krause EG. Phosphorylation of the L-type calcium channel ß-subunit is involved in ß-adrenergic signal transduction in canine myocardium. FEBS Lett. 1993;335:217-222. [Medline] [Order article via Infotrieve]
14. Klöckner U, Itagaki K, Bodi I, Schwartz A. ß-Subunit expression is required for cAMP-dependent increase of cloned cardiac and vascular calcium channel currents. Pflugers Arch. 1992;420:413-415. [Medline] [Order article via Infotrieve]
15. Yoshida A, Takahashi M, Nishimura S, Takeshima H, Kokubun S. Cyclic AMP-dependent phosphorylation and regulation of the cardiac dihydropyridine-sensitive Ca channel. FEBS Lett. 1992;309:343-349. [Medline] [Order article via Infotrieve]
16.
Sculptoreau A, Rotman E, Takahashi M, Scheuer T, Catterall WA.
Voltage-dependent potentiation of the activity of cardiac L-type
calcium channel
1 subunits due to phosphorylation by
cAMP-dependent protein kinase. Proc Natl Acad Sci U S A.
1993;90: 10135-10139.
17.
Singer D, Biel M, Lotan L, Flockerzi V, Hofmann F, Dascal N.
The roles of the subunits in the function of the calcium channel.
Science. 1991;253:1553-1557.
18.
Williams ME, Brust PF, Feldman DH, Patthi S, Simerson S,
Maroufi A, McCue AF, Veligebi G, Ellis SB, Harpold MM. Structure and
functional expression of an
-conotoxin-sensitive human N-type
calcium channel. Science. 1992;257:389-395.
19. Lory P, Nargeot J. Cyclic AMP-dependent modulation of cardiac Ca channels expressed in Xenopus laevis oocytes. Biochem Biophys Res Commun. 1992;182:1059-1065. [Medline] [Order article via Infotrieve]
20.
Yatani A, Wakamori M, Mikala G, Bahinski A. Block of transient
outward-type cloned cardiac K+ channel currents by
quinidine. Circ Res. 1993;73:351-359.
21. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S, Numa S. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature. 1989;340:230-233. [Medline] [Order article via Infotrieve]
22.
Ruth P, Röhrkasten A, Biel M, Bosse E, Regulla S, Meyer
HE, Flockerzi V, Hofmann F. Primary structure of the ß subunit of the
DHP-sensitive calcium channel from skeletal muscle. Science. 1989;245:1115-1118.
23.
Waechter DE, Baserga R. Effect of methylation on expression of
microinjected genes. Proc Natl Acad Sci U S A. 1982;79:1106-1110.
24.
Kaufman RJ, Sharp PA. Construction of a modular dihydrofolate
reductase cDNA gene: analysis of signals utilized for efficient
expression. Mol Cell Biol. 1982;2:1304-1319.
25.
O'Hare K, Benoist C, Breathnach R. Transformation of mouse
fibroblasts to methotrexate resistance by a recombinant plasmid
expressing a prokaryotic dihydrofolate reductase. Proc Natl Acad
Sci U S A. 1981;78:1527-1531.
26. Fukuda K, Higashida H, Kubo T, Maeda A, Akiba I, Bujo H, Mishina M, Numa S. Selective coupling with K+ currents of muscarinic acetylcholine receptor subtypes in NG108-15 cells. Nature. 1988;335:355-358. [Medline] [Order article via Infotrieve]
27. Mishina M, Kurosaki T, Robimatsu T, Morimoto Y, Noda M, Yamamoto T, Terao M, Lindstrom J, Takahashi T, Kuno M, Numa S. Expression of functional acetylcholine receptor from cloned cDNAs. Nature. 1984;307:604-608. [Medline] [Order article via Infotrieve]
28. Green SA, Holt BD, Liggett SB. ß1- and ß2-adrenergic receptors display subtype-selective coupling to Gs. Mol Pharmacol. 1992;41:889-893. [Abstract]
29. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159. [Medline] [Order article via Infotrieve]
30. Mori Y, Friedich T, Kim M-S, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, Furuichi T, Mikoshiba K, Imoto K, Tanabe T, Numa S. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature. 1991;350:394-402.
31. Hamilton SL, Yatani A, Brush K, Schwartz A, Brown AM. A comparison between binding and electrophysiological effects of dihydropyridines on cardiac membranes. Mol Pharmacol. 1987;31:221-231. [Abstract]
32. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76-85. [Medline] [Order article via Infotrieve]
33. Liggett SB, Bouvier M, Hausdorff WP, O'Dowd B, Caron MG, Lefkowitz RJ. Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant ß2-adrenergic receptors lacking phosphorylation sites. Mol Pharmacol. 1989;36:641-646. [Abstract]
34.
Yatani A, Okabe K, Birnbaumer L, Brown AM. Detergents, dimeric
Gß
, and eicosanoid pathways to muscarinic atrial K+
channels. Am J Physiol. 1990;258:H1507-H1514.
35. Nakagawa T, Shirasaki T, Wakamori M, Fukuda A, Akaike N. Excitatory amino acid response in isolated nucleus tractus solitari neurons of the rat. Neurosci Res. 1990;8:114-123. [Medline] [Order article via Infotrieve]
36.
Bean BP. Two kinds of calcium channels in canine atrial cells.
Differences in kinetics, selectivity, and pharmacology. J Gen
Physiol. 1985;86:1-30.
37.
Kokubun S, Reuter H. Dihydropyridine derivatives prolong the
open state of Ca channels in cultured cardiac cells. Proc Natl
Acad Sci U S A. 1984;81:4824-4827.
38.
Yatani A, Codina J, Imoto K, Reeves JP, Birnbaumer L, Brown
AM. A G protein directly regulates mammalian cardiac calcium channels.
Science. 1987;238:1288-1292.
39. Bean BP, Mowycky MC, Tsien RW. ß-Adrenergic modulation of calcium channels in frog ventricular heart cells. Nature. 1984;307:371-375. [Medline] [Order article via Infotrieve]
40. Tiaho F, Nargeot J, Richard S. Voltage-dependent regulation of L-type cardiac Ca channels by isoproterenol. Pflugers Arch. 1991;419:596-602. [Medline] [Order article via Infotrieve]
41. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem. 1991;60:653-688. [Medline] [Order article via Infotrieve]
42.
Bosse E, Bottlender R, Kleppisch T, Hescheler J, Welling A,
Hofmann F, Flockerzi V. Stable and functional expression of the calcium
channel
1 subunit from smooth muscle in somatic cell
lines. EMBO J. 1992;11:2033-2038. [Medline]
[Order article via Infotrieve]
43.
Welling A, Bosse E, Cavalié A, Bottlender R, Ludwig A,
Nastainczyk W, Flockerizi V, Hofmann F. Stable co-expression of calcium
channel,
1, ß and
2/
subunits in a somatic cell line. J Physiol (Lond). 1993;471:749-765.
44. Perez-Reyes E, Yuan W, Wei X, Bers DM. Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett. 1994;342:119-123. [Medline] [Order article via Infotrieve]
45.
Levy FO, Zhu X, Kaumann J, Birnbaumer L. Efficacy of
ß1-adrenergic receptors is lower than that of
ß2-adrenergic receptors. Proc Natl Acad Sci U S
A. 1993;90:10798-10802.
This article has been cited by other articles:
![]() |
J. Miriyala, T. Nguyen, D. T. Yue, and H. M. Colecraft Role of CaV{beta} Subunits, and Lack of Functional Reserve, in Protein Kinase A Modulation of Cardiac CaV1.2 Channels Circ. Res., April 11, 2008; 102(7): e54 - e64. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Hulme, R. E. Westenbroek, T. Scheuer, and W. A. Catterall Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation PNAS, October 31, 2006; 103(44): 16574 - 16579. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Qu, G. Baroudi, Y. Yue, N. El-Sherif, and M. Boutjdir Localization and modulation of {alpha}1D (Cav1.3) L-type Ca channel by protein kinase A Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2123 - H2130. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Erxleben, C. Gomez-Alegria, T. Darden, Y. Mori, L. Birnbaumer, and D. L. Armstrong Modulation of cardiac CaV1.2 channels by dihydropyridine and phosphatase inhibitor requires Ser-1142 in the domain III pore loop PNAS, March 4, 2003; 100(5): 2929 - 2934. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Keef, J. R. Hume, and J. Zhong Regulation of cardiac and smooth muscle Ca2+ channels (CaV1.2a,b) by protein kinases Am J Physiol Cell Physiol, December 1, 2001; 281(6): C1743 - C1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mochly-Rosen, G. Wu, H. Hahn, H. Osinska, T. Liron, J. N. Lorenz, A. Yatani, J. Robbins, and G. W. Dorn II Cardiotrophic Effects of Protein Kinase C {epsilon} : Analysis by In Vivo Modulation of PKC{epsilon} Translocation Circ. Res., June 9, 2000; 86(11): 1173 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lehmann-Horn and K. Jurkat-Rott Voltage-Gated Ion Channels and Hereditary Disease Physiol Rev, October 1, 1999; 79(4): 1317 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Dorn II, N. M. Tepe, J. N. Lorenz, W. J. Koch, and S. B. Liggett Low- and high-level transgenic expression of beta 2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galpha q-overexpressing mice PNAS, May 25, 1999; 96(11): 6400 - 6405. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wakamori, M. Strobeck, T. Niidome, T. Teramoto, K. Imoto, and Y. Mori Functional Characterization of Ion Permeation Pathway in the N-Type Ca2+ Channel J Neurophysiol, February 1, 1998; 79(2): 622 - 634. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |